Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV open-label study of Copegus with Pegasys in chronic hepatitis C
2005-003932-23Phase 4Completed
- Sponsor
- Roche
- Start
- Sep 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ribavirin and interferon alfa in hepatitis C virus infection, sponsored by Roche. Primary endpoints: Frequency and severity of adverse events and End of clinical trial. Started Sep 2005; status: completed.
02
Drugs
ribavirininterferon alfa
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2005-003932-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003932-23.